Rocco Latorre Selected Research

propionamide

1/2022

Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rocco Latorre Research Topics

Disease

10	Pain (Aches) 01/2022 - 01/2018
6	Hyperalgesia 01/2022 - 01/2018
4	Constipation 01/2022 - 01/2015
4	Colitis 01/2022 - 01/2018
3	Chronic Pain 01/2022 - 12/2019
3	Hypersensitivity (Allergy) 01/2020 - 01/2018
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2019 - 01/2018
2	Inflammation (Inflammations) 01/2022 - 12/2014
2	Visceral Pain 01/2022 - 01/2018
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2022 - 09/2021
2	Obesity 01/2016 - 04/2010
1	Migraine Disorders (Migraine) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Tongue Neoplasms (Tongue Neoplasm) 09/2021
1	Squamous Cell Carcinoma of Head and Neck 09/2021
1	Neoplasms (Cancer) 09/2021
1	Mouth Neoplasms (Oral Cancer) 09/2021
1	Cancer Pain 09/2021
1	Abdominal Pain (Pain, Abdominal) 01/2020
1	Diarrhea 01/2019
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2018
1	Autoimmune enteropathy 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2015
1	Celiac Disease (Celiac Sprue) 01/2015
1	Neurologic Manifestations (Neurological Manifestations) 01/2015
1	Portal Hypertension 11/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2012
1	Fibrosis (Cirrhosis) 11/2012
1	Body Weight (Weight, Body) 04/2010

Drug/Important Bio-Agent (IBA)

4	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 01/2018
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2022 - 12/2019
2	CytokinesIBA 01/2022 - 12/2014
2	Aprepitant (Emend)FDA Link 01/2022 - 12/2019
2	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 01/2021
2	cathepsin SIBA 09/2021 - 01/2018
2	Opioid Analgesics (Opioids)IBA 01/2020 - 12/2019
1	AminesIBA 01/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	propionamideIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022
1	PolymersIBA 01/2022
1	Calcitonin Gene-Related PeptideIBA 01/2022
1	AnkyrinsIBA 01/2022
1	Calcitonin Receptors (Calcitonin Receptor)IBA 01/2022
1	ArrestinIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Dynamin IIIBA 01/2022
1	PAR-2 ReceptorIBA 01/2022
1	Receptor Activity-Modifying Protein 1IBA 01/2022
1	Neurokinin-1 Receptor AntagonistsIBA 01/2022
1	LY3000328IBA 09/2021
1	LigandsIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	delta Opioid Receptors (delta Opioid Receptor)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Chemokine CX3CL1IBA 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	Glutens (Glutelin)IBA 01/2020
1	Substance PIBA 12/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Serotonin (5 Hydroxytryptamine)IBA 01/2019
1	Protamines (Protamine Sulfate)FDA Link 06/2018
1	OpsinsIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Halorhodopsins (Halorhodopsin)IBA 01/2018
1	Pancreatic Elastase (Elastase)IBA 01/2018
1	ClathrinIBA 01/2018
1	TrypsinIBA 01/2018
1	ChannelrhodopsinsIBA 01/2018
1	Dynamins (Dynamin)IBA 01/2018
1	AutoantibodiesIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2015
1	AntibodiesIBA 01/2015
1	ChemokinesIBA 12/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2012
1	Amibegron hydrochlorideIBA 11/2012
1	EndocannabinoidsIBA 04/2010
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2010

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2018
1	Analgesia 01/2021
1	Spinal Injections 12/2019
1	Cannula 01/2018
1	Lasers (Laser) 01/2018